OmniCyte Founder, Peter Leonardi, provides insight into the emerging field of immunotherapy. Immunotherapy is the…
Browsing: tumors
Threshold Pharmaceuticals takes advantage of the differences in metabolic activity between cancerous and normal, healthy biological tissue.
The Aliso Viejo, Calif.-based company achieved several major milestones in 2009.
The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector.